Skip to main content Accessibility help
×
×
Home

Muscarinic Binding and Choline Acetyltransferase in Postmortem Brains of Demented Patients

  • Steven B. Waller (a1), Melvyn J. Ball (a2), Mark A. Reynolds (a3) and Edythe D. London (a4)

Abstract:

Postmortem human brain samples were taken from non-neurological controls as well as demented subjects who died with Alzheimer's disease (AD), multi-infarct dementia (MID), or a combination of AD and MID dementia (MIXED). Choline acetyltransferase (Ch AT) activity was measured radiometrically using [ 1 -l4C]acetyl-coenzyme A as the substrate, muscarinic binding was assayed with [3H]quinuclidinyl benzilate, and the proportion of binding associated with high affinity agonist sites was measured by carbamylcholine displacement of the radioligand.

Relative to control, ChAT activity was significantly reduced (p ≤0.01) in samples taken from the temporal, frontal, and hippocampal areas of demented patients. A small elevation in Bmax was noted in the hippocampal endplate (p ≤0.01) (AD vs. control) and the H1-subiculum region (p ≤0.05) (AD vs. all other groups). In addition, the percentage of binding associated with high affinity agonist sites was greater in the frontal cortex of AD and MID samples (p≤0.05), compared with MIXED and control, and in the temporal cortex of the AD group compared with all other groups (p≤0.05). The results suggest a regionally specific upregulation of cerebral muscarinic receptors in dementia, especially in AD.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Muscarinic Binding and Choline Acetyltransferase in Postmortem Brains of Demented Patients
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Muscarinic Binding and Choline Acetyltransferase in Postmortem Brains of Demented Patients
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Muscarinic Binding and Choline Acetyltransferase in Postmortem Brains of Demented Patients
      Available formats
      ×

Copyright

Corresponding author

Department of Physiology and Pharmacology, University of South Dakota School of Medicine, Vermillion, SD 57069 USA

References

Hide All
1.Terry, R, Davies, P.Dementia of the Alzheimer-type. Ann Rev Neurosci 1980; 3: 7795.
2.Gottfries, C-G, Adolfsson, R, Aquilonius, S-M, et al. Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT). Neurobiol Aging 1983; 4: 261271.
3.Hardy, J, Adolfsson, R, Alafuzoff, I, et al. Transmitters deficits in Alzheimer’s disease. Neurochem Int 1985; 7: 545563.
4.Ball, M, Merskey, H, Fisman, M, et al. Hippocampal morphometry in Alzheimer dementia: Implications for neurochemical hypotheses. In: Katzman, R ed. Banbury Report 15: BiologicalAspeas ofAlzheimer’s Disease. Cold Spring Harbor, Maine: Cold Spring Harbor Laboratories, 1983; 4557.
5.Bull, G, Oderfeld-Nowak, B. Standardization of a radiometric assay of choline acetyltransferase and a study of the activation of the enzyme in rabbit brain. J Neurochem 1971; 19: 14211428.
6.McKinney, M and Coyle, J.Regulation of neocortical muscarinic receptors: Effects of drug treatments and lesions. J Neurosci 1982;2:97105.
7.Waller, S, Ball, M, Reynolds, M, et al. Muscarinic binding in postmor- tem brains of demented patients. Neurobiol Aging 1985; (submitted).
8.Lowry, O, Rosebrough, N, Farr, A, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265275.
9.Nie, N, Hull, C, Jenkins, J, et al. Statistical Package for the Social Sciences. New York: McGraw-Hill, 1975.
10.Keppel, G.Design and Analysis: A Researcher’s Handbook. Engle- wood Cliffs, California: Prentice-Hall, 1973. Lang, W and Henke, H. Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of the Alzheimer-type patients. Brain Res 1983; 267: 271280.
11.Perry, E, Tomlinson, B, Blessed, G, et al. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 1978; 2: 1457–59.
12.Bowen, D, White, P, Spillane, J,et al. Accelerated aging or selective neuron loss as an important cause of dementia. Lancet 1979; 1: 1114.
13.Wilcock, G, Esiri, M, Bowen, D, et al. Alzheimer’s disease: Correla- tion of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci 1982;57:407417.
14.Davies, P, Verth, A.Regional distribution of muscarinic acetylcho- line receptor in normal and Alzheimer’s type dementia brains. Brain Res 1978; 138: 385392.
15.Jenni-Eiermann, S, von Hahn, HP, Honeggar, CG, et al. Studies on neurotransmitter binding in senile dementia: Comparison of Alzheimer’s and Mixed Vascular-Alzheimer’s dementias. Gerontology 1984; 30: 350358.
16.Nordberg, A, Larsson, C, Adolsfsson, R, et al. Muscarinic receptor compensation in hippocampus of Alzheimer patients. J Neural Transmission 1983; 56: 1319.
17.Perry, E.The cholinergic system in old age and Alzheimer’s disease. Age and Ageing 1980; 9: 18.
18.Caulfield, M, Straughan, D, Cross, A, et al. Cortical muscarinic receptor subtypes and Alzheimer’s disease. Lancet 1982; 1: 1277.
19.Palacios, J.Autoradiographic localization of muscarinic choliner- gic receptors in the hippocampus of patients with senile dementia. Brain Res 1982; 243: 173175.
20.Lang, W, Henke, H.Cholinergic receptor binding and autoradiogra- phy in brains of non-neurological and senile dementia of the Alzheimer-type patients. Brain Res 1983; 267: 271280.
21.Reisine, T, Yamamura, H, Bird, E, et al. Pre- and postsynaptic neurochemical alterations in Alzheimer’s disease. Brain Res 1978; 159: 477481.
22.Perry, E, Perry, R.The cholinergic system in Alzheimer’s disease. In: Roberts, P. ed. Biochemistry of Dementia New York: John Wiley and Sons, 1980; 135183.
23.Rinne, J, Laakso, K, Lonnberg, P, et al. Brain muscarinic receptors in senile dementia. Brain Res 1985; 336: 1925.
24.Rinne, J, Rinne, J, Laakso, K, et al. Reduction in muscarinic recep- tor binding in limbic areas of Alzheimer brain. J Neurol Neurosurg Psychiatry 1984; 47: 651652.
25.Mash, D, Flynn, D and Potter, L . Loss of M2 muscarinic receptors in the cerebral cortex in Alzheimer’s disease and experimental cholinergic denervation. Science 1985; 228: 11151117.
26.Ben-Barak, J, Dudai, Y.Scopalamine induces an increase in musca- rinic receptor level in rat hippocampus. Brain Res 1980; 193: 309313.
27.Simon, R, Klein, W.Cholinergic activity regulates muscarinic recep- tors in nervous system cultures. Proc Natl Acad Sci USA 1979; 76: 41414145.
28.Burt, D.Muscarinic receptor binding in rat sympathetic ganglia is unaffected by denervation. Brain Res 1978; 143: 573579.
29.Sachs, D, Kloog, Y, Korczyn, A, et al. Denervation supersensivity and muscarinic receptors in the cat iris. Biochem Pharmacol 1978; 28: 15131518.
30.Reisine, T, Fields, J, Yamamura, H, et al. Neurotransmitter receptor alterations in Parkinson’s disease. Life Sci 1977; 21: 335344.
31.Ruberg, M, Ploska, A, Javoy-Agid, F, et al. Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia. Brain Res 1982; 232: 129139.
32.Hyman, BT, Van Hoesen, GW, Damasio, AR, et al. Alzhemier’s Disease: Cell-specific pathology isolates the hippocampal formation. Science 1984; 225: 11681170.
33.Ball, MJ, Fisman, M, Hachinski, V, et al. A new definition of Alzeimer’s Disease: a hippocampal dementia. Lancet 1985; 1: 1416.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Canadian Journal of Neurological Sciences
  • ISSN: 0317-1671
  • EISSN: 2057-0155
  • URL: /core/journals/canadian-journal-of-neurological-sciences
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed